France Geographic Atrophy Market (2025-2031) | Outlook, Size & Revenue, Share, Competitive Landscape, Industry, Trends, Segmentation, Analysis, Forecast, Value, Companies, Growth

Market Forecast By Age Group (Above 60 Years, Above 75 Years), By Diagnosis (Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (MfERG)), By Therapeutic Agents Clinical Phase (Late-Stage (Phase III), Phase II, Phase I) And Competitive Landscape
Product Code: ETC7219893 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • France Geographic Atrophy Market Outlook
  • Market Size of France Geographic Atrophy Market, 2024
  • Forecast of France Geographic Atrophy Market, 2031
  • Historical Data and Forecast of France Geographic Atrophy Revenues & Volume for the Period 2021- 2031
  • France Geographic Atrophy Market Trend Evolution
  • France Geographic Atrophy Market Drivers and Challenges
  • France Geographic Atrophy Price Trends
  • France Geographic Atrophy Porter's Five Forces
  • France Geographic Atrophy Industry Life Cycle
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Age Group for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Above 60 Years for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Above 75 Years for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Diagnosis for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Fundus Autofluorescence (FAF) for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Optical Coherence Tomography Angiography (OCT-A) for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Multifocal Electroretinography (MfERG) for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Therapeutic Agents Clinical Phase for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Late-Stage (Phase III) for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Phase II for the Period 2021- 2031
  • Historical Data and Forecast of France Geographic Atrophy Market Revenues & Volume By Phase I for the Period 2021- 2031
  • France Geographic Atrophy Import Export Trade Statistics
  • Market Opportunity Assessment By Age Group
  • Market Opportunity Assessment By Diagnosis
  • Market Opportunity Assessment By Therapeutic Agents Clinical Phase
  • France Geographic Atrophy Top Companies Market Share
  • France Geographic Atrophy Competitive Benchmarking By Technical and Operational Parameters
  • France Geographic Atrophy Company Profiles
  • France Geographic Atrophy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the France Geographic Atrophy Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the France Geographic Atrophy Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 France Geographic Atrophy Market Overview

3.1 France Country Macro Economic Indicators

3.2 France Geographic Atrophy Market Revenues & Volume, 2021 & 2031F

3.3 France Geographic Atrophy Market - Industry Life Cycle

3.4 France Geographic Atrophy Market - Porter's Five Forces

3.5 France Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.6 France Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 France Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F

4 France Geographic Atrophy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in France

4.2.2 Growing geriatric population in France leading to higher incidence of geographic atrophy

4.2.3 Advancements in healthcare technology and treatment options for geographic atrophy in France

4.3 Market Restraints

4.3.1 High cost of treatment and limited access to healthcare services for some segments of the population in France

4.3.2 Regulatory challenges and approval processes for new geographic atrophy therapies in France

5 France Geographic Atrophy Market Trends

6 France Geographic Atrophy Market, By Types

6.1 France Geographic Atrophy Market, By Age Group

6.1.1 Overview and Analysis

6.1.2 France Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F

6.1.3 France Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F

6.1.4 France Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F

6.2 France Geographic Atrophy Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 France Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F

6.2.3 France Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F

6.2.4 France Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F

6.3 France Geographic Atrophy Market, By Therapeutic Agents Clinical Phase

6.3.1 Overview and Analysis

6.3.2 France Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F

6.3.3 France Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F

6.3.4 France Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F

7 France Geographic Atrophy Market Import-Export Trade Statistics

7.1 France Geographic Atrophy Market Export to Major Countries

7.2 France Geographic Atrophy Market Imports from Major Countries

8 France Geographic Atrophy Market Key Performance Indicators

8.1 Average time from diagnosis to treatment initiation for geographic atrophy patients in France

8.2 Patient satisfaction with available treatment options for geographic atrophy in France

8.3 Percentage of healthcare professionals trained in diagnosing and treating geographic atrophy in France

9 France Geographic Atrophy Market - Opportunity Assessment

9.1 France Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.2 France Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 France Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F

10 France Geographic Atrophy Market - Competitive Landscape

10.1 France Geographic Atrophy Market Revenue Share, By Companies, 2024

10.2 France Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All